Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R I Fisher

Showing results (1-10 of 200) with videos related to

Pageof 20
Sort By:
The Cancer Journal From Scientific American|April 9, 1998
Relapse after successful treatment with immunotherapy: lessons for the futureR I Fisher
Cancer|November 1, 1994
Treatment of aggressive non-Hodgkin' lymphomas. Lessons from the past 10 yearsR I Fisher
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Report of workshop 5: early high-dose chemotherapyR I Fisher
Important Advances in Oncology|January 1, 1990
CHOP chemotherapy as standard therapy for treatment of patients with diffuse histiocytic lymphomaR I Fisher
Cancer Treatment Reports|April 1, 1982
Implications of persistent T cell abnormalities for the etiology of Hodgkin's diseaseR I Fisher
Cancer Chemotherapy and Pharmacology|January 1, 1997
Cyclophosphamide, doxorubicin, vincristine, and prednisone versus intensive chemotherapy in non-Hodgkin's lymphomaR I Fisher
Journal of the National Cancer Institute|January 4, 2001
Autologous bone marrow transplantation for aggressive non-Hodgkin's lymphoma: lessons learned and challenges remainingR I Fisher
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2001
Treating Hodgkin's disease with bispecific antibodies: Both patients and antibody are limitingR I Fisher
Seminars in Oncology|February 28, 2001
Current therapeutic paradigm for the treatment of non-Hodgkin's lymphomaR I Fisher
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 1999
Treatment of grey zone lymphomasR I Fisher
Pageof 20

Showing results (1-10 of 200) with videos related to

Sort By:
Pageof 20
The Cancer Journal From Scientific American|April 9, 1998
Relapse after successful treatment with immunotherapy: lessons for the futureR I Fisher
Cancer|November 1, 1994
Treatment of aggressive non-Hodgkin' lymphomas. Lessons from the past 10 yearsR I Fisher
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Report of workshop 5: early high-dose chemotherapyR I Fisher
Important Advances in Oncology|January 1, 1990
CHOP chemotherapy as standard therapy for treatment of patients with diffuse histiocytic lymphomaR I Fisher
Cancer Treatment Reports|April 1, 1982
Implications of persistent T cell abnormalities for the etiology of Hodgkin's diseaseR I Fisher
Cancer Chemotherapy and Pharmacology|January 1, 1997
Cyclophosphamide, doxorubicin, vincristine, and prednisone versus intensive chemotherapy in non-Hodgkin's lymphomaR I Fisher
Journal of the National Cancer Institute|January 4, 2001
Autologous bone marrow transplantation for aggressive non-Hodgkin's lymphoma: lessons learned and challenges remainingR I Fisher
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2001
Treating Hodgkin's disease with bispecific antibodies: Both patients and antibody are limitingR I Fisher
Seminars in Oncology|February 28, 2001
Current therapeutic paradigm for the treatment of non-Hodgkin's lymphomaR I Fisher
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 1999
Treatment of grey zone lymphomasR I Fisher
Pageof 20